BA
HPTX

BlackRock Advisors’s HYPERION THERAPEUTICS INC COM STK (DE) HPTX Stock Holding History

BlackRock Advisors’s Portfolio HPTX Stock Details HPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-20,156
Closed -$925K – 3813
2015
Q1 		$925K Sell
20,156
-90,938
-82% -$2.72M ﹤0.01% 1612
2014
Q4 		$2.67M Buy
111,094
+71,032
+177% +$1.6M ﹤0.01% 1117
2014
Q3 		$1.01M Buy
40,062
+12,976
+48% +$322K ﹤0.01% 1429
2014
Q2 		$707K Buy
27,086
+22,578
+501% +$580K ﹤0.01% 1754
2014
Q1 		$116K Buy
4,508
+436
+11% +$11.8K ﹤0.01% 2968
2013
Q4 		$82K Buy
4,072
+190
+5% +$4.47K ﹤0.01% 3120
2013
Q3 		$101K Buy
3,882
+93
+2% +$2.33K ﹤0.01% 2963
2013
Q2 		$83K Buy
+3,789
New +$83K ﹤0.01% 2997

BlackRock Advisors's HPTX Position: Q2 2015 in Review

BlackRock Advisors sold out of HYPERION THERAPEUTICS INC COM STK (DE) (HPTX) in Q2 2015, closing a stake of 20,156 shares — an estimated $925K sold.

BlackRock Advisors first reported a position in HPTX in Q2 2013 and held it in 8 quarters. The position peaked at $2.67M in Q4 2014. 0 funds tracked by Wall St. Rank hold HPTX as of Q2 2015.

  • BlackRock Advisors reported no remaining HYPERION THERAPEUTICS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • BlackRock Advisors sold 20,156 HYPERION THERAPEUTICS INC COM STK (DE) shares in Q2 2015, an estimated $925K.
  • BlackRock Advisors first reported a position in HYPERION THERAPEUTICS INC COM STK (DE) in Q2 2013 and held it in 8 quarters.
  • BlackRock Advisors's HYPERION THERAPEUTICS INC COM STK (DE) position peaked at $2.67M in Q4 2014.
  • 0 funds tracked by Wall St. Rank held HYPERION THERAPEUTICS INC COM STK (DE) as of Q2 2015.

Based on BlackRock Advisors's 13F filing for Q2 2015, filed 7 Aug 2015.